Heritable defects of the human TLR signalling pathways

Journal of Endotoxin Research

Volumn 11, Issue 4, 2005, Pages 220-224

  Puel, Anne ^a   Yang, Kun ^a,b   Ku, Cheng Lung ^a   von Bernuth, Horst ^a   Bustamante, Jacinta ^a   Santos, Orchidée Filipe ^a   Lawrence, Tatiana ^a   Chang, Huey Hsuan ^a   Al Mousa, Hamoud ^a,c   Picard, Capucine ^a,c   Casanova, Jean Laurent ^a,b,c  

^a IMAGINE INSTITUTE   (France)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Anhidrotic ectodermal dysplasia; Heritable defects; Human TLR signalling; IKBA; IRAK4; NEMO

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANHIDROTIC ECTODERMAL DYSPLASIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CYTOKINE PRODUCTION; GENE MUTATION; HERITABILITY; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IN VITRO STUDY; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; X CHROMOSOME LINKED DISORDER;

ECTODERMAL DYSPLASIA; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; MUTATION; NF-KAPPA B; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

POSIBACTERIA;

EID: 25444437914     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805105X37367     Document Type: Article

References (33)

1. Lemaitre B. The road to Toll. Nat Rev Immunol 2004;, 4: 521-527.
2. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3: 169-176.
3. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
4. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
5. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430: 257-263.
6. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/Toll-like receptor superfamily. Curr Top Microbiol Immunol 2002; 270: 47-61.
7. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
8. Beutler B, Du X, Hoebe K. From phenomenon to phenotype and from phenotype to gene: forward genetics and the problem of sepsis. J Infect Dis 2003; 187: S321-S326.
9. Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leukoc Biol 2004; 75: 749-755.
10. Qureshi ST, Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun 2003; 4: 87-94.
11. Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 2004; 4: 55-66.
12. Ku CL, Yang K, Bustamante J et al. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol Rev 2005; 203: 10-20.
13. Courtois G, Smahi A, Reichenbach J et al. A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003; 112: 1108-1115.
14. Janssen R, van Wengen A, Hoeve MA et al. The same IκBα mutation in two related individuals leads to completely different clinical syndromes. J Exp Med 2004; 200: 559-568.
15. Abinun M, Spickett G, Appleton AL, Flood T, Cant AJ. Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr 1996; 155: 146-147.
16. Carrol ED, Gennery AR, Flood TJ, Spickett GP, Abinun M. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch Dis Child 2003; 88: 340-341.
17. von Bernuth H, Puel A, Ku C-L et al. Septicaemia without sepsis: inherited disorders of NF-κB-mediated inflammation. Clin Infect Dis 2005; In press.
18. Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol 2004; 16: 34-41.
19. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109: S81-S96.
20. Orange JS, Levy O, Brodeur SR et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol 2004; 114: 650-656.
21. Niehues T, Reichenbach J, Neubert J et al. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 2004; 114: 1456-1462.
22. Picard C, Puel A, Bustamante J, Ku CL, Casanova JL. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 2003; 3: 451-459.
23. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001; 2: 223-228.
24. Doffinger R, Smahi A, Bessia C et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27: 277-285.
25. Dupuis-Girod S, Corradini N, Hadj-Rabia S et al. Osteopetrosis, lymphedema, anhidrotiic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 2002; 109: e97.
26. Orange JS, Brodeur SR, Jain A et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 2002; 109: 1501-1509.
27. Nishikomori R, Akutagawa H, Maruyama K et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood 2004; 103: 4565-4572.
28. Picard C, Puel A, Bonnet M et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003; 299: 2076-2079.
29. Medvedev AE, Lentschat A, Kuhns DB et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med 2003; 198: 521-531.
30. Enders A, Pannicke U, Berner R et al. Two siblings with lethal pneumococcal meningitis in a family with a mutation in interleukin-1 receptor-associated kinase 4. J Pediatr 2004; 145: 698-700.
31. Chapel H, Puel A, von Bernuth H, Picard C, Casanova JL. Shigella sonnei meningitis in a 10-year-old girl due to IRAK-4 deficiency - first association with a primary immune deficiency. Clin Infect Dis 2005; 40: 1227-1231.
32. Currie AJ, Davidson DJ, Reid GS et al. Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling. J Pediatr 2004; 144: 512-518.
33. Day N, Tangsinmankong N, Ochs H et al. Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses. J Pediatr 2004; 144: 524-526.